Stay updated on FLT3 Inhibitor Combo in AML Clinical Trial
Sign up to get notified when there's something new on the FLT3 Inhibitor Combo in AML Clinical Trial page.

Latest updates to the FLT3 Inhibitor Combo in AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe revision history now includes a new entry for Revision: v3.6.3 and the previous Revision: v3.6.0 is removed from the history, representing a minor metadata update to the record viewer.SummaryDifference0.0%

- Check29 days agoChange DetectedThe recruitment status was updated to 'No longer looking for participants,' indicating the study is not enrolling; the history now shows a new revision tag (v3.6.0) replacing the previous one (v3.5.5).SummaryDifference0.1%

- Check36 days agoChange DetectedThe revision line on the history page was updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a new version of the page template or data.SummaryDifference0.0%

- Check58 days agoChange DetectedA new revision entry appears: v3.5.4 replaces the previous v3.5.3 in the page history, reflecting an update to the revision metadata.SummaryDifference0.0%

- Check79 days agoChange DetectedClinicalTrials.gov’s page revision indicator was updated from v3.5.0 to v3.5.3, reflecting a technical/UI release rather than a change to the study record itself.SummaryDifference0.0%

- Check115 days agoChange DetectedFooter revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to FLT3 Inhibitor Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FLT3 Inhibitor Combo in AML Clinical Trial page.